Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy

In the 1980s, the111 In-labeled somatostatin analog OctreoScan (Covidien, Hazelwood, MO) was developed for imaging of somatostatin receptor subtype 2 (sst2 ) overexpressing tumors. On the basis of this success, peptide receptor radionuclide therapy (PRRT) was developed using similar somatostatin ana...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in nuclear medicine 2010-05, Vol.40 (3), p.209-218
Hauptverfasser:	Pool, Stefan E., MD, Krenning, Eric P., MD, PhD, Koning, Gerben A., PhD, van Eijck, Casper H.J., MD, PhD, Teunissen, Jaap J.M., MD, PhD, Kam, Boen, MD, Valkema, Roelf, MD, PhD, Kwekkeboom, Dik J., MD, PhD, de Jong, Marion, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Alpha Particles Animals Clinical Trials as Topic Drug Delivery Systems Drug Evaluation, Preclinical Humans Isotope Labeling - methods Neoplasms - metabolism Neoplasms - radiotherapy Peptides - chemistry Peptides - pharmacokinetics Peptides - therapeutic use Radioisotopes - chemistry Radioisotopes - therapeutic use Radiology Receptors, Peptide - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!